Genetic Variant in GRM1 Underlies Congenital Cerebellar Ataxia with No Obvious Intellectual Disability

Metabotropic glutamate receptor 1 (mGluR1) plays a crucial role in slow excitatory postsynaptic conductance, synapse formation, synaptic plasticity, and motor control. The gene is expressed mainly in the brain, with the highest expression in the cerebellum. Mutations in the gene have previously been...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of molecular sciences Vol. 24; no. 2; p. 1551
Main Authors Protasova, Maria S, Andreeva, Tatiana V, Klyushnikov, Sergey A, Illarioshkin, Sergey N, Rogaev, Evgeny I
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 12.01.2023
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Metabotropic glutamate receptor 1 (mGluR1) plays a crucial role in slow excitatory postsynaptic conductance, synapse formation, synaptic plasticity, and motor control. The gene is expressed mainly in the brain, with the highest expression in the cerebellum. Mutations in the gene have previously been known to cause autosomal recessive and autosomal dominant spinocerebellar ataxias. In this study, whole-exome sequencing of a patient from a family of Azerbaijani origin with a diagnosis of congenital cerebellar ataxia was performed, and a new homozygous missense mutation in the gene was identified. The mutation leads to the homozygous amino acid substitution of p.Thr824Arg in an evolutionarily highly conserved region encoding the transmembrane domain 7, which is critical for ligand binding and modulating of receptor activity. This is the first report in which a mutation has been identified in the last transmembrane domain of the mGluR1, causing a congenital autosomal recessive form of cerebellar ataxia with no obvious intellectual disability. Additionally, we summarized all known presumable pathogenic genetic variants in the gene to date. We demonstrated that multiple rare variants in the underlie a broad diversity of clinical neurological and behavioral phenotypes depending on the nature and protein topology of the mutation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1422-0067
1661-6596
1422-0067
DOI:10.3390/ijms24021551